{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T14:46:07Z","timestamp":1724597167368},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s11908-008-0028-5","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T03:30:19Z","timestamp":1210822219000},"source":"Crossref","is-referenced-by-count":12,"title":["Clostridium difficile infection: A critical overview"],"prefix":"10.1007","volume":"10","author":[{"given":"Bayan","family":"Missaghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"August J.","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Robert C.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,16]]},"reference":[{"key":"28_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1086\/518874","volume":"45","author":"D.B. Blossom","year":"2007","unstructured":"Blossom DB, McDonald LC: The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 2007, 45:222\u2013227.","journal-title":"Clin Infect Dis"},{"key":"28_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/IPC.0b013e3180686491","volume":"15","author":"R.C. Owens Jr","year":"2007","unstructured":"Owens RC Jr, Valenti AJ: Clostridium difficile-associated disease in the new millenium: \u201cthe perfect storm\u201d has arrived. Infect Dis Clin Pract 2007, 15:299\u2013315.","journal-title":"Infect Dis Clin Pract"},{"key":"28_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/infdis\/136.5.701","volume":"136","author":"J.G. Bartlett","year":"1977","unstructured":"Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL: Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. J Infect Dis 2004, 190:202\u2013209.","journal-title":"J Infect Dis"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0016-5085(78)90457-2","volume":"75","author":"J.G. Bartlett","year":"1978","unstructured":"Bartlett JG, Moon N, Chang TW, et al.: Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978, 75:778\u2013782.","journal-title":"Gastroenterology"},{"key":"28_CR5","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1056\/NEJMoa051639","volume":"353","author":"V.G. Loo","year":"2005","unstructured":"Loo VG, Poirier L, Miller MA, et al.: A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442\u20132449.","journal-title":"N Engl J Med"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2307\/30141083","volume":"16","author":"D.N. Gerding","year":"1995","unstructured":"Gerding DN, Johnson S, Peterson LR, et al.: Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995, 16:459\u2013477.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl2","key":"28_CR7","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1086\/519258","volume":"45","author":"L. Valiquette","year":"2007","unstructured":"Valiquette L, Cossette B, Garant MP, et al.: Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1\/027 strain. Clin Infect Dis 2007, 45(Suppl 2):S112\u2013S121.","journal-title":"Clin Infect Dis"},{"key":"28_CR8","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","volume":"294","author":"S. Dial","year":"2005","unstructured":"Dial S, Delaney JA, Barkun AN, Suissa S: Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005, 294:2989\u20132995.","journal-title":"JAMA"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1503\/cmaj.1040876","volume":"171","author":"S. Dial","year":"2004","unstructured":"Dial S, Alrasadi K, Manoukian C, et al.: Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004, 171:33\u201338.","journal-title":"CMAJ"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/archinte.166.22.2518","volume":"166","author":"S.V. Kazakova","year":"2006","unstructured":"Kazakova SV, Ware K, Baughman B, et al.: A hospital Outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006, 166:2518\u20132524.","journal-title":"Arch Intern Med"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ajic.2006.06.004","volume":"35","author":"L.V. McFarland","year":"2007","unstructured":"McFarland LV, Beneda HW, Clarridge JE, Raugi GJ: Implications of the changing face of Clostridium difficile disease for health care practitioners. Am J Infect Control 2007, 35:237\u2013253.","journal-title":"Am J Infect Control"},{"key":"28_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jcp.2003.015875","volume":"57","author":"S.S. Johal","year":"2004","unstructured":"Johal SS, Lambert CP, Hammond J, et al.: Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea. J Clin Pathol 2004, 57:973\u2013979.","journal-title":"J Clin Pathol"},{"issue":"Suppl4","key":"28_CR13","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1093\/clinids\/16.Supplement_4.S239","volume":"16","author":"M.E. Mulligan","year":"1993","unstructured":"Mulligan ME, Miller SD, McFarland LV, et al.: Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile. Clin Infect Dis 1993, 16(Suppl 4):S239\u2013S244.","journal-title":"Clin Infect Dis"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/502539","volume":"26","author":"C.A. Muto","year":"2005","unstructured":"Muto CA, Pokrywka M, Shutt K, et al.: A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005, 26:273\u2013280.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1086\/520276","volume":"26","author":"S. Johnson","year":"1998","unstructured":"Johnson S, Gerding DN: Clostridium difficile-associated diarrhea. Clin Infect Dis 1998, 26:1027\u20131034.","journal-title":"Clin Infect Dis"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00003495-200767040-00001","volume":"67","author":"R.C. Owens","year":"2007","unstructured":"Owens RC: Clostridium difficile-associated disease: changing epidemiology and implications for management. Drugs 2007, 67:487\u2013502.","journal-title":"Drugs"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1086\/382084","volume":"38","author":"D.N. Gerding","year":"2004","unstructured":"Gerding DN: Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004, 38:646\u2013648.","journal-title":"Clin Infect Dis"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J. Pepin","year":"2005","unstructured":"Pepin J, Saheb N, Coulombe MA, et al.: Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254\u20131260.","journal-title":"Clin Infect Dis"},{"key":"28_CR19","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1086\/521859","volume":"46","author":"R.C. Owens Jr","year":"2008","unstructured":"Owens RC Jr, Donskey CJ, Gaynes RP, et al.: Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008, 46:S19\u2013S31.","journal-title":"Clin Infect Dis"},{"key":"28_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00000658-200203000-00008","volume":"235","author":"R.M. Dallal","year":"2002","unstructured":"Dallal RM, Harbrecht BG, Boujoukas AJ, et al.: Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002, 235:363\u2013372.","journal-title":"Ann Surg"},{"key":"28_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/427113","volume":"40","author":"M.C. McEllistrem","year":"2005","unstructured":"McEllistrem MC, Carman RJ, Gerding DN, et al.: A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 2005, 40:265\u2013272.","journal-title":"Clin Infect Dis"},{"key":"28_CR22","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa051590","volume":"353","author":"L.C. McDonald","year":"2005","unstructured":"McDonald LC, Killgore GE, Thompson A, et al.: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433\u20132441.","journal-title":"N Engl J Med"},{"key":"28_CR23","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1128\/JCM.41.3.1118-1125.2003","volume":"41","author":"M. Rupnik","year":"2003","unstructured":"Rupnik M, Kato N, Grabnar M, Kato H: New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 2003, 41:1118\u20131125.","journal-title":"J Clin Microbiol"},{"key":"28_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1128\/CMR.18.2.247-263.2005","volume":"18","author":"D.E. Voth","year":"2005","unstructured":"Voth DE, Ballard JD: Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005, 18:247\u2013263.","journal-title":"Clin Microbiol Rev"},{"key":"28_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","volume":"366","author":"M. Warny","year":"2005","unstructured":"Warny M, Pepin J, Fang A, et al.: Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079\u20131084.","journal-title":"Lancet"},{"key":"28_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S0140-6736(00)02819-1","volume":"356","author":"M.H. Wilcox","year":"2000","unstructured":"Wilcox MH, Fawley WN: Hospital disinfectants and spore formation by Clostridium difficile. Lancet 2000 356:1324.","journal-title":"Lancet"},{"key":"28_CR27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1086\/519201","volume":"28","author":"W.N. Fawley","year":"2007","unstructured":"Fawley WN, Underwood S, Freeman J, et al.: Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol 2007, 28:920\u2013925.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"28_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/00004836-199709000-00018","volume":"25","author":"S.V. Nash","year":"1997","unstructured":"Nash SV, Bourgeault R, Sands M: Colonic disease associated with a positive assay for Clostridium difficile toxin: a retrospective study. J Clin Gastroenterol 1997, 25:476\u2013479.","journal-title":"J Clin Gastroenterol"},{"key":"28_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.idc.0000228074.67531.98","volume":"14","author":"N.D. Nielsen","year":"2006","unstructured":"Nielsen ND, Layton BA, McDonald LC, et al.: Changing epidemiology of Clostridium difficile-associated disease: experience and perception of infectious diseases consultants. Infect Dis Clin Pract 2006, 14:296\u2013302.","journal-title":"Infect Dis Clin Pract"},{"key":"28_CR30","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1128\/JCM.39.5.1996-1998.2001","volume":"39","author":"A. Lozniewski","year":"2001","unstructured":"Lozniewski A, Rabaud C, Dotto E, et al.: Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains. J Clin Microbiol 2001, 39:1996\u20131998.","journal-title":"J Clin Microbiol"},{"key":"28_CR31","first-page":"4","volume":"23","author":"J. Cloud","year":"2007","unstructured":"Cloud J, Kelly CP: Update on Clostridium difficile associated disease. Curr Opin Gastroenterol 2007, 23:4\u20139.","journal-title":"Curr Opin Gastroenterol"},{"key":"28_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/512550","volume":"28","author":"D.N. Gerding","year":"2007","unstructured":"Gerding DN: New definitions will help, but cultures are critical for resolving unanswered questions about Clostridium difficile. Infect Control Hosp Epidemiol 2007, 28:113\u2013115.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"28_CR33","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.27.10.2386-2387.1989","volume":"27","author":"C.R. Clabots","year":"1989","unstructured":"Clabots CR, Gerding SJ, Olson MM, et al.: Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure. J Clin Microbiol 1989, 27:2386\u20132387.","journal-title":"J Clin Microbiol"},{"key":"28_CR34","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/521860","volume":"46","author":"D.N. Gerding","year":"2008","unstructured":"Gerding DN, Muto CA, Owens RC Jr: Treatment of Clostridium difficile infection. Clin Infect Dis 2008, 46:S32\u2013S42.","journal-title":"Clin Infect Dis"},{"key":"28_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jcp.56.2.126","volume":"56","author":"J. Freeman","year":"2003","unstructured":"Freeman J, Wilcox MH: The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces. J Clin Pathol 2003, 56:126\u2013128.","journal-title":"J Clin Pathol"},{"key":"28_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1099\/00222615-28-3-217","volume":"28","author":"S. Kamiya","year":"1989","unstructured":"Kamiya S, Yamakawa K, Ogura H, Nakamura S: Recovery of spores of Clostridium difficile altered by heat or alkali. J Med Microbiol 1989, 28:217\u2013221.","journal-title":"J Med Microbiol"},{"key":"28_CR37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/CMR.10.4.597","volume":"10","author":"W.A. Rutala","year":"1997","unstructured":"Rutala WA, Weber DJ: Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 1997, 10:597\u2013610.","journal-title":"Clin Microbiol Rev"},{"key":"28_CR38","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1086\/318149","volume":"31","author":"J.L. Mayfield","year":"2000","unstructured":"Mayfield JL, Leet T, Miller J, Mundy LM: Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000, 31:995\u20131000.","journal-title":"Clin Infect Dis"},{"key":"28_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/524329","volume":"29","author":"P.C. Carling","year":"2008","unstructured":"Carling PC, Parry MF, Von Beheren SM: Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol 2008, 29:1\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"28_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"T.H. Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE Jr, et al.: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159\u2013177.","journal-title":"Clin Infect Dis"},{"key":"28_CR41","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/522654","volume":"45","author":"C.A. Muto","year":"2007","unstructured":"Muto CA, Blank MK, Marsh JW, et al.: Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive \u201cbundle\u201d approach. Clin Infect Dis 2007, 45:1266\u20131273.","journal-title":"Clin Infect Dis"},{"key":"28_CR42","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","volume":"343","author":"C.J. Donskey","year":"2000","unstructured":"Donskey CJ, Chowdhry TK, Hecker MT, et al.: Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000, 343:1925\u20131932.","journal-title":"N Engl J Med"},{"key":"28_CR43","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1086\/346153","volume":"36","author":"E. Lautenbach","year":"2003","unstructured":"Lautenbach E, LaRosa LA, Marr AM, et al.: Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003, 36:440\u2013446.","journal-title":"Clin Infect Dis"},{"key":"28_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1086\/519265","volume":"45","author":"F.A. Zar","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KM, Davis MB: A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302\u2013307.","journal-title":"Clin Infect Dis"},{"key":"28_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0002-9343(89)90223-4","volume":"86","author":"R. Fekety","year":"1989","unstructured":"Fekety R, Silva J, Kauffman C, et al.: Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989, 86:15\u201319.","journal-title":"Am J Med"},{"key":"28_CR46","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","volume":"97","author":"L.V. McFarland","year":"2002","unstructured":"McFarland LV, Elmer GW, Surawicz CM: Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002, 97:1769\u20131775.","journal-title":"Am J Gastroenterol"},{"key":"28_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1086\/506351","volume":"43","author":"D.M. Musher","year":"2006","unstructured":"Musher DM, Logan N, Hamill RJ, et al.: Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis 2006, 43:421\u2013427.","journal-title":"Clin Infect Dis"},{"key":"28_CR48","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1086\/501137","volume":"42","author":"T.J. Louie","year":"2006","unstructured":"Louie TJ: Treatment of first recurrences of Clostridium difficile-associated disease: waiting for new treatment options. Clin Infect Dis 2006, 42:765\u2013767.","journal-title":"Clin Infect Dis"},{"key":"28_CR49","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1128\/AAC.01623-06","volume":"51","author":"D.W. Hecht","year":"2007","unstructured":"Hecht DW, Galang MA, Sambol SP, et al.: In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother 2007, 51:2716\u20132719.","journal-title":"Antimicrob Agents Chemother"},{"key":"28_CR50","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1345\/aph.1H332","volume":"40","author":"D. Surowiec","year":"2006","unstructured":"Surowiec D, Kuyumjian AG, Wynd MA, Cicogna CE: Past, present, and future therapies for Clostridium difficile-associated disease. Ann Pharmacother 2006, 40:2155\u20132163.","journal-title":"Ann Pharmacother"},{"key":"28_CR51","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1128\/AAC.48.6.2280-2282.2004","volume":"48","author":"G. Ackermann","year":"2004","unstructured":"Ackermann G, Loffler B, Adler D, Rodloff AC: In vitro activity of OPT-80 against Clostridium difficile. Antimicrob Agents Chemother 2004, 48:2280\u20132282.","journal-title":"Antimicrob Agents Chemother"},{"key":"28_CR52","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1345\/aph.1H340","volume":"40","author":"T.Z. Jodlowski","year":"2006","unstructured":"Jodlowski TZ, Oehler R, Kam LW, Melnychuk I: Emerging therapies in the treatment of Clostridium difficile-associated disease. Ann Pharmacother 2006, 40:2164\u20132169.","journal-title":"Ann Pharmacother"},{"key":"28_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1086\/506349","volume":"43","author":"T.J. Louie","year":"2006","unstructured":"Louie TJ, Peppe J, Watt CK, et al.: Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis 2006, 43:411\u2013420.","journal-title":"Clin Infect Dis"},{"key":"28_CR54","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1128\/IAI.00982-06","volume":"74","author":"G.J. Babcock","year":"2006","unstructured":"Babcock GJ, Broering TJ, Hernandez HJ, et al.: Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters. Infect Immun 2006, 74:6339\u20136347.","journal-title":"Infect Immun"},{"key":"28_CR55","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","volume":"128","author":"S. Sougioultzis","year":"2005","unstructured":"Sougioultzis S, Kyne L, Drudy D, et al.: Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 2005, 128:764\u2013770.","journal-title":"Gastroenterology"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-008-0028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-008-0028-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-008-0028-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-008-0028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T04:02:41Z","timestamp":1581998561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-008-0028-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s11908-008-0028-5","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]},"article-number":"165"}}